Commission Aversion

Fear of making a harmful mistake can push someone toward doing nothing at all, even when acting would clearly help. Inaction just feels safer than risking a mistake.

This bias disproportionately weights the costs of wrongful action relative to omission, skewing choices toward inaction. It shows up as an asymmetric loss evaluation within the decision-making process itself.

A parent notices their child has a mild but persistent fever. Afraid that giving the wrong medication could make things worse, they repeatedly choose to do nothing — even as the fever climbs and the inaction ends up causing more harm than a simple dose of children's medicine would have.

A Data Safety Monitoring Board reviewing a clinical trial faces accumulating evidence of modest but consistent drug efficacy with a low adverse-event rate. Action-linked risks — drug-induced side effects, regulatory liability — get assigned disproportionate weight relative to the cost of continued placebo-arm suffering and delayed access to benefit. The threshold for stopping the trial early gets raised well beyond what a symmetric expected-utility calculation would justify, and the control-arm status quo persists longer than it should. A loss-function audit that explicitly maps the omission-pathway harm against the action-pathway harm reveals the asymmetry and allows the threshold to be recalibrated toward the actual expected value.

The bad outcomes that might follow from acting get imagined vividly, and that imagined harm dominates the thinking. Fear of causing that harm is what pushes the choice toward doing nothing.

Action-linked negative outcomes receive elevated salience while the costs of omission get systematically downweighted, creating an asymmetry across the decision. Structural thresholds and loss-sensitive gating bias the resulting policy toward the default of non-action.

Pointing out the clear benefits of acting, and showing that the risks are actually small, is the direct fix. Concrete examples where acting helped make the case for action.

Reframing the decision by explicitly quantifying the omission costs, and calibrating loss weights to the true expected values, corrects the imbalance directly. Decision aids that normalize occasional action, with thresholds adjusted accordingly, reduce the underlying asymmetry.

Missed beneficial interventions; Suboptimal status quo persistence; Avoidable harm from nonresponse

An adversarial actor can weaponize commission aversion by framing corrective actions as high-risk or potentially harmful, creating institutional paralysis. For example, flooding a regulatory body with contested evidence about intervention side-effects can suppress enforcement action. In litigation or policy contexts, opponents can strategically raise speculative harms of acting to exploit the asymmetric loss-weighting architecture. Propagandists can manufacture moral narratives where acting equates to culpability while omission is cast as passive innocence, reinforcing the bias at scale and locking decision-makers into inertial non-intervention.

Decision-makers can build resistance by explicitly quantifying omission costs alongside commission costs in structured decision aids to force symmetric loss accounting. Implementing pre-mortem exercises that surface missed-intervention failures—not just action-caused harms—recalibrates threshold gating toward expected-value reasoning. Institutional protocols requiring documented justification for inaction equivalent to those required for action reduce the structural asymmetry. Regular audits of loss-function assignments across action and inaction pathways expose weighting distortions and enable retroactive threshold calibration.